SCHEMBL13290348

SCHEMBL13290348

Cc1ccc(N)c2c1C(=O)NC2=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 3/20 0.50
ADORA2A P29274 3/20 0.41
CSNK1A1 P48729 2/20 0.41
CSNK1D P48730 2/20 0.41
CSNK1G1 Q9HCP0 2/20 0.41
FGR P09769 1/20 0.41
PIM1 P11309 1/20 0.41
MAOA P21397 1/20 0.41
DYRK1A Q13627 1/20 0.41
HIPK2 Q9H2X6 1/20 0.41
CSNK2A2 P19784 1/20 0.40
CSNK2B P67870 1/20 0.40
CSNK2A1 P68400 1/20 0.40
CSNK2A3 Q8NEV1 1/20 0.40
PARP1 P09874 2/20 0.39
POLB P06746 5/20 0.37
CYP3A4 P08684 4/20 0.37
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
TDP1 Q9NUW8 4/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11519039 0.88 PARP1 (0.44) PARP1POLBCES1
SCHEMBL7429649 0.88 THRB (0.55) THRBADORA2ACSNK1A1CSNK1DCSNK1G1
SCHEMBL8274198 0.79 PARP1 (0.40) PIM1PARP1POLBCES1
SCHEMBL14750382 0.78 THRB (0.74) THRBADORA2ACSNK1A1CSNK1DCSNK1G1
SCHEMBL14839396 0.78 THRB (0.74) THRBADORA2ACSNK1A1CSNK1DCSNK1G1
SCHEMBL6468586 0.77 PARP1 (0.50) THRBADORA2ACSNK1A1CSNK1DCSNK1G1
SCHEMBL3039233 0.76 MEN1 (0.50) THRBADORA2ACSNK1A1CSNK1DCSNK1G1
SCHEMBL11152933 0.76 ADORA2A (0.50) THRBADORA2ACSNK1A1CSNK1DCSNK1G1
SCHEMBL31717008 0.76 MEN1 (0.50) THRBADORA2ACSNK1A1CSNK1DCSNK1G1
SCHEMBL5171611 0.72 PARP1 (0.46) THRBMAOAPARP1POLBCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745641-B2 Nitrogen-containing heterocyclic compound KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-06-29 US disclosed
US-20090054407-A1 Nitrogen-containing heterocyclic compound KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054407-A1 Nitrogen-containing heterocyclic compound NR4A1, NR5A2, PRMT8 THRB 1098/4885ADORA2A 1278/4885CSNK1A1 661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.